StocksFin Logo
Boston Scientific Corporation country of incorporation
|
|
Mr. Michael Mahoney
|
41,000 employees
NYSE | Healthcare | Medical Devices
McKesson Corporation country of incorporation
|
|
Mr. Brian Tyler
|
58,000 employees
NYSE | Healthcare | Medical Distribution
Q322 reported Nov 3, 2022 Reporting Period
$3.17B 8.1% vs. Q321 Revenues Q322
69.12% 0.4% vs. Q321 Gross Profit Margin
5.49% -61.6% vs. Q321 Net Profit Margin
320M -31.2% vs. Q321 Free Cash Flow Q322
$0.12 -57.1% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.03%
Q223
0.15%
Q223 reported Nov 2, 2022 Reporting Period
$70.16B 5.4% vs. Q222 Revenues Q223
4.41% -12.4% vs. Q222 Gross Profit Margin
1.32% 229.1% vs. Q222 Net Profit Margin
985M -45% vs. Q222 Free Cash Flow Q223
$6.47 274% vs. Q222 EPS Q223
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.03%
Q223
0.15%
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
0.62
0.49
Current Ratio
1.45
0.93
Cash Ratio
0.1
0.06
Price to Book
3.14
-21.54
Price to Sales
17.49
0.75
Price to Earnings
79.66
12.25